Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. November 2017 07:30 ET | Quelle: Meridian Bioscience Inc.

Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2018 Cash Dividend Rate, and Reaffirms Fiscal 2018 Guidance

GENERAL HIGHLIGHTS CINCINNATI, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: reported fourth quarter and full-year fiscal 2017 net revenues of $49.7 million and...
23. Oktober 2017 17:30 ET | Quelle: Meridian Bioscience Inc.

Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to Magellan Diagnostics

CINCINNATI, Oct. 23, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that the FDA has issued a Warning Letter related to matters at its Magellan Diagnostics...
19. Oktober 2017 07:30 ET | Quelle: Meridian Bioscience Inc.

Meridian Bioscience, Inc. Comments on Preliminary Fiscal 2017 Operating Results and Provides Fiscal 2018 Revenue and Earnings Guidance

CINCINNATI, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that based on preliminary results, it expects revenues for fiscal 2017, ended on September 30,...
16. Oktober 2017 16:30 ET | Quelle: Meridian Bioscience Inc.

Meridian Bioscience, Inc. Expects to Report Fiscal 2018 Revenue and Earnings Guidance on Thursday, October 19, 2017

CINCINNATI, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and life science component company, expects to release its fiscal 2018 Revenue and...
10. Oktober 2017 11:50 ET | Quelle: Meridian Bioscience, Inc.

Meridian Bioscience, Inc. Appoints Jack Kenny as Chief Executive Officer

CINCINNATI, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has appointed John (Jack) P. Kenny as Chief Executive Officer, effective October 9,...
19. September 2017 09:00 ET | Quelle: Meridian Bioscience, Inc.

Meridian Contributes to Upcoming “LEADCON 2017” – Third Annual International Conference on the Prevention of Lead and Heavy Metal Toxicity in Hyderabad, India

CINCINNATI, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that Magellan Diagnostics, Inc., a business unit of Meridian, will support and participate in...
05. September 2017 14:22 ET | Quelle: Meridian Bioscience, Inc.

Meridian Launches TRU Block® ULTRA – A Powerful Immunoassay Interference Blocker

CINCINNATI, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Meridian Life Science, Inc., (MLS) of Memphis, Tennessee, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the...
09. August 2017 13:30 ET | Quelle: Meridian Bioscience, Inc.

Meridian Initiates Clinical Trials for New Neonatal Saliva CMV illumigene Test

CINCINNATI, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has initiated clinical trials for a new illumigene CMV molecular amplification test....
08. August 2017 14:31 ET | Quelle: Meridian Bioscience, Inc.

Meridian Bioscience Introduces the Expansion of Its ImmunoCard STAT!® Product Line

CINCINNATI, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the expansion of its ImmunoCard STAT!® product line with the addition of ImmunoCard STAT! FLU...
08. August 2017 10:00 ET | Quelle: Meridian Bioscience, Inc.

Meridian Bioscience Elects John Rice to the Board of Directors

CINCINNATI, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that its Board of Directors elected a new independent director, John M. Rice, Ph.D., effective...

Vorherige Seite

Nächste Seite